Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models
Early Prediction of Acute Exacerbations of COPD Using Wearable and Portable Remote Monitoring Technology With AI/ML Empowered Platforms: A Prospective Clinical Study
McGill University Health Centre/Research Institute of the McGill University Health Centre
50 participants
May 22, 2025
OBSERVATIONAL
Conditions
Summary
This study is aimed to collect real-time physiological data using two wearable devices (a biometric ring and a biometric wristband), daily lung mechanical measurements by a handheld oscillometer, and participant-reported symptoms in patients with COPD remotely from their home environment. The data will be used to train and validate artificial intelligence and machine learning (AI/ML) models to predict COPD exacerbations in advance of their actual occurrence. The data will also be used to test the new severity classification system for exacerbations of COPD, as well as to determine important relationships between physiological measurements from the wearable devices, the handheld oscillometer, the self-reported symptoms, and the tests performed at the baseline visit.
Eligibility
Inclusion Criteria5
- Males/females, age ≥ 40, former/current smokers with ≥10 pack-year smoking history
- FEV1/FVC \< 0.7, with 80% \< FEV1 ≤50% (moderate, 'GOLD 2') 50% \< FEV1 ≤ 30% (severe, 'GOLD 3') or FEV1 \< 30% (very severe, 'GOLD 4') COPD
- History of 2 or more exacerbations in the preceding 12 months requiring corticosteroids, antibiotics, or both
- Ability to provide informed consent
- Ability to access internet at least once daily
Exclusion Criteria2
- No existing COPD diagnosis
- Any medical/cognitive/functional condition which renders inability to operate research equipment/devices, and/or to complete daily symptom response
Interventions
In this study, participants will be equipped with biometric wearable devices, i.e. ring and wristband, as well as with a handheld oscillometer, to measure their physiological parameters and lung mechanical changes (lung function).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06802003